Pay in 4 interest-free payments of $16.25 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
AZD-2281 was approved in 2014 for treating advanced ovarian cancer
S-4-nitrophenylmethyl-6-thioinosine
the combination of a GSK3 inhibitor (CHIR99021
(-)-Narwedine reduces the action of AChE and therefore tends to increase the concentration of acetylcholine in the brain
Azeliragon HCl - CAS# 1284150-65-7 size:10mg solid AZD-2281 was approved in 2014Azeliragon HCl, CAS No. 1284150 65 7, also known as TTP488 and PF 04494700, is a potent and orally active RAGE inhibitor. RAGE (receptor for advanced glycation endproducts) is a pattern recognition receptor, which affects the movement of amyloid, an Alzheimer's associated protein, into the brain. In preclinical studies, azeliragon decreased brain amyloid in mice and improved their performance on behavior tests. Azeliragon is a promising agent for for
US$ 225.00
US$ 127.50
US$ 647.50
US$ 970.00
US$ 375.00
US$ 125.00
US$ 1015.00
US$ 1880.00
US$ 25.00